Toxins produced by Bacillus anthracis and other microbial pathogens require functions of host cell genes to yield toxic effects. Here we show that low density lipoprotein receptorrelated protein 6 (LRP6), previously known to be a coreceptor for the Wnt signaling pathway, is required for anthrax toxin lethality in mammalian cells. Downregulation of LRP6 or coexpression of a truncated LRP6 dominant-negative peptide inhibited cellular uptake of complexes containing the protective antigen (PA) carrier of anthrax toxin moieties and protected targeted cells from death, as did antibodies against epitopes in the LRP6 extracellular domain. Fluorescence microscopy and biochemical analyses showed that LRP6 enables toxin internalization by interacting at the cell surface with PA receptors TEM8/ATR and/or CMG2 to form a multicomponent complex that enters cells upon PA binding. Our results, which reveal a previously unsuspected biological role for LRP6, identify LRP6 as a potential target for countermeasures against anthrax toxin lethality.
INTRODUCTION
Anthrax, a lethal disease of humans and other animals caused by the gram-positive spore-forming eubacterium, Bacillus anthracis (Leppla, 2000; Bhatnagar and Batra, 2001; Collier and Young, 2003) , has been the focus of both biological interest and bioterrorism concerns. The virulence of B. anthracis infection is produced by separate complexes formed by interaction of a carrier protein, protective antigen (PA, 83 kDa) with lethal factor (LF, 90 kDa) or edema factor (EF, 89 kDa) (Singh et al., 1989) moieties.
During infection by B. anthracis, PA binds to receptors on the cell surface and is cleaved by the protease furin, releasing a 20 kDa fragment and enabling the residual receptor-bound C-terminal 63 kDa PA peptide fragment (PA63) to form heptamers which can interact with LF or EF. After entering target cells, PA/LF and PA/EF complexes translocate across the endosomal membrane into the cytosol where they dissociate, allowing LF and EF to exert their toxic effects (Leppla, 2000) . LF is a Zn 2+ protease that cleaves the amino terminus of nearly all MAPK kinases (Duesbery et al., 1998; Vitale et al., 1998) . EF is a calmodulin-dependent adenylate cyclase that elevates intracellular levels of cAMP, producing profound clinical edema and impairing the immune response to infection (O'Brien et al., 1985; Hoover et al., 1994) . Two distinct cell surface proteins act as receptors for PA: ATR (anthrax toxin receptor) (Bradley et al., 2001; Liu and Leppla, 2003) , which is encoded by alternatively spliced transcripts of the tumor endothelial marker 8 (TEM8) gene (Carson-Walter et al., 2001) , and CMG2, which has 60% identity with ATR and is encoded by capillary morphogenesis gene 2 (Scobie et al., 2003) . Low density lipoprotein receptor-related protein 6 (LRP6) is a member of a gene family encoding low-density lipoprotein receptors (LDLRs) that reside on the cell surface and participate in endocytosis of their ligands (Stefansson et al., 1995; Howell and Herz, 2001; Yu et al., 2001) . As a key component of a complex that mediates the transduction of signals from secreted Wnt proteins to b catenin, LRP6 functions in the regulation of embryogenesis and cell proliferation (e.g., Pinson et al., 2000; Tamai et al., 2000; Semenov et al., 2001) . During experiments that used expressed sequence tags (ESTs) to inactivate chromosomal genes in human cell populations (Lu et al., 2004) , together with a phenotypic screen for cellular genes required for anthrax toxicity, we discovered that LRP6 interacts with the anthrax toxin receptors TEM8/ATR and CGM2 to promote entry into the cytoplasm of PA/receptor complexes and consequently that LRP6 deficiency mitigates the effects of anthrax toxin. Our studies identify LRP6 as a potential target for the prophylaxis and treatment of anthrax cytotoxicity.
RESULTS

Isolation and Characterization of Cells Showing Decreased Toxin Susceptibility
We designed a phenotypic screen aimed at discovering cellular genes that specifically affect the actions of PA in the pathway to anthrax toxicity. In these experiments, we used a transactivated tetracycline (Tet)-controlled promoter (Tet-off system) (Gossen and Bujard, 1992; Gossen et al., 1995) on the lentiviral vector pLEST to activate antisense transcription $40,000 human ESTs (Lu et al., 2004) introduced into a population of M2182 human prostate carcinoma cells. We then isolated clones resistant to killing by a mixture of PA and FP59, a fusion of the PA binding domain of LF to the ADP ribosylation domain of Pseudomonas aeruginosa exotoxin A. As PA enables the entry of FP59 into cells and exotoxin-A mediated lethality (Arora and Leppla, 1992) , we reasoned that cells made defective in PA internalization by antisense expression of ESTs would show decreased killing by PA + FP59.
Screening of a cell library having an estimated complexity of 2 Â 10 5 independent insertions of the pLEST construct in chromosomes of M2182 cells yielded 73 colonies resistant to PA + FP59, nine of which showed downregulation of resistance by tetracycline. ATR43, a clone that survived a PA concentration >25-fold the concentration that was lethal in the parental cell line when combined with 50 ng/ml of FP59 ( Figure 1A ), was selected for further study. Growth of ATR43 cells for 48 hr in the presence of Tet (1 mg/ml) decreased their ability to survive exposure to the toxin while having little effect on growth of the parental line ( Figure 1B) . Analysis of the PCR-amplified EST present in ATR43 revealed a single chromosomally integrated sequence that corresponds to a $228 nt image clone (image clone 285207, accession number N66273) (Hillier et al., 1996) annotated in GenBank as an intron located between exons 21 and 22 of the low-density lipoprotein receptor-related protein 6 (lrp6) gene. This cDNA had been cloned in pLEST 3 0 to the Tet-regulated lentiviral promoter and in antisense orientation relative to the promoter.
Decreased Expression of LRP6 Results in Toxin Resistance
Western blot analysis of ATR43 cell extracts ( Figure 1C ) indicated decreased intensity of bands migrating at the previously identified positions of LRP6 monomer and dimer (Liu et al., 2003a) , as detected with murine monoclonal antibody directed against an epitope present in both LRP6 and the related protein, LRP5. We confirmed the identity of these bands as LRP6 monomers and dimers by electrophoresis of lysates containing an N-terminally-tagged Flag-LRP6 protein in SDS-PAGE in the presence of the reducing agent b mercaptoethanol (b ME), followed by immunoblotting with anti-Flag antibody ( Figure 1D ); the two highly reproducible faint bands migrating more slowly than the Flag-tagged LRP6 dimer ( Figure 1C ) may represent multimeric forms of LRP6. The biological effects of reduction of LRP6 protein in ATR43 were evident also from the observed impairment of the cellular response of this clone to Wnt, as indicated by sharply decreased activity of a b catenin-regulated promoter on the Super8XTOP-flash reporter plasmid (Veeman et al., 2003) , which was introduced into this cell clone ( Figure 1E ).
While the above experiments argue strongly for the role of LRP6 in the phenotype observed for ATR43 cells, assignment of the EST sequence that mediates tetracycline-dependent regulation of toxin resistance in ATR43 cells to a region of the lrp6 gene that has been annotated in GenBank as an intron prompted additional studies to further establish the causal role of LRP6 deficiency in toxin (C) Immunoblot analysis of lysates from naïve M2182tTA and mutant clone ATR43 cells using murine monoclonal antibody directed against human LRP5/6. a tubulin bands were measured in Western blots as internal controls. In SDS-PAGE gels, LRP6 appeared in both monomer (*) and dimer (**) forms in the presence of the reducing agent, b mercaptoethanol (b ME). (D) Confirmation of the molecular nature of both monomer (*) and dimer (**) bands of LRP6 proteins. N-terminal-tagged Flag-LRP6 was transfected into 293T cell, and the expressing lysates from transiently transfected cells electrophoresed under SDS-PAGE conditions in the presence of b ME were probed in immunoblots using anti-Flag monoclonal antibody. (E) Effect of LRP6 deficiency on cellular response to Wnt activation. The data shown are the summed results of three independent experiments. The values shown represent the mean and standard deviation (bars). siRNA-sc refers to a scrambled sequence siRNA control. (F) Effect of LRP6 deficiency induced in naïve cells. The EST identified in the ATR43 mutant was reintroduced into pLEST in the antisense orientation. Pooled populations of infected M2182tTA clones in 6-well plates were treated with PA/FP59 and photographed by microscopy at a magnification of 100 Â. M2182/pLEST-LIB refers to EST library in M2182 cells serving as a control. (G) Effect of lrp6-specific siRNA on transcript abundance. lrp6 transcripts were measured by quantitative RT-PCR and normalized to b actin mRNA. Filled-in bars indicate transcript abundance compared with wild-type M2182. Each data point represents an average of three repeats. The values shown represent the mean and standard deviation (bars). (H and I) Immunoblot assays of lysates of M2182 cells expressing siRNAs directed against lrp6 transcripts. Antibodies used for detection were rabbit polyclonal antibody H300 (H) against human LRP6 protein and murine monoclonal antibody against human LRP5/6 (I). Anti-a-tubulin antibody was used to calibrate loading of lysates on gels. Both monomer (*) and dimer (**) forms of LRP6 protein bands are shown. Antibody specificity was confirmed by blotting the same membrane using antibody that had been preabsorbed with an excess of the peptide used as the immunogen (I, middle). (J and K) Cytotoxicity of PA + FP59 in M2182 cells treated with siRNAs (J) and in M2182/siRNA3 cells expressing LRP6 protein (K). Cell viability was assessed as described in Figure 1A . Two individual M2182/siRNA3 clones expressing the mutant LRP6m3 construct were subjected to the PA + FP59 toxin assay (K). A clone containing the expression vector alone (pcDNA3.1) was included as a control for effects of the extended procedure per se on siRNA-modulated interference with toxicity. (A) Effect of LRP6 deficiency on mouse macrophage sensitivity to PA + LF. pLENTI-SUPER constructs expressing siRNAs directed against murine lrp6 transcripts were introduced into RAW264.7 cells by transfection, and the cells acquiring the vector were selected by blasticidin and pooled for cytotoxicity assays. Controls were RAW264.7 cells expressing human lrp6 siRNA1, which shares no homology with the mouse lrp6 sequence, and the naïve RAW264.7 cells not subjected to transfection. Cells at 1 Â 10 3 cells per well in 96-well plates were treated with serially diluted PA and 500 ng/ml of LF for 2 days. Cell viability was assessed using MTT assay as described in Figure 1A . This experiment was repeated five times with separate transfection assays, and similar quantitative differences in experimental and control samples were observed.
(B and C) Western blot analysis of bound (B) and internalized (C) PA in different cells was conducted following the protocol as described in Experimental Procedures. PA83 is the full-length form of PA (83 kDa), and the oligomer represents the heptamer of PA63. a tubulin abundance was measured as an internal control.
resistance. First, a plasmid (pATR43) containing cDNA of image clone 285207 that was newly inserted into the pLEST vector in antisense orientation with respect to the Tet-regulated promoter was introduced into naïve M2182tTA cells. As was observed for ATR43, these cells showed decreased sensitivity to PA + FP59 ( Figure 1F ), confirming the role of the EST sequence in toxin resistance. The effects of inactivating lrp6 on the sensitivity of M2182 cells to PA + FP59 were further confirmed in cell clones that stably produced 21-23 nt siRNAs complementary to three different exonic sequences of lrp6 mRNA. Downregulation of lrp6 transcripts by two of these siRNAs, siRNA1 and siRNA3, was observed by quantitative RT-PCR ( Figure 1G ) along with (1) reduction of the steady-state level of LRP6 protein as indicated by the summed densities of LRP6 monomer and multimer bands (Figures 1H and 1I) ; (2) an impaired cellular response to Wnt activation ( Figure 1E ); and (3) reduced toxin susceptibility ( Figure 1J ). Preabsorption of the peptide employed as immunogen resulted in disappearance of the Western blot signals ( Figure 1I , middle panel), although the ratio of LRP6 monomer and dimer varied in different experiments and for different LRP6 antibodies. That the observed siRNA effects on toxin-induced lethality resulted from inhibition of LRP6 function was further confirmed by concurrent overexpression of full-length lrp6 cDNA in two independent toxin-resistant clones ( Figure 1K ; M2182/siRNA3 carrying pLRP6m3-4 or pLRP6m3-8 versus M2182/siRNA3 carrying pcDNA3.1 vector alone). In these experiments, we created silent mutations at seven sites in the 21-nucleotide sequence targeted by the siRNA to prevent siRNA3 inhibition of the overexpressed lrp6 cDNA. Using a fixed concentration of FP59 (50 ng/ml), the calculated values of EC 50 (effective concentration of PA required to kill 50% of cells tested) were increased 4.3-to 5.1-fold (calculated values for M2182, M2182/siRNA3_ pLRP6m3-4, M2182/siRNA3_pLRP6m3-8, and M2182/ siRNA3_pcDNA3.1 are 3 Â 10 À11 M, 5.4 Â 10 À10 M, 4.5 Â 10 À10 M, and 2.3 Â 10 À9 M, respectively).
LRP6 Deficiency Results in Impaired Binding and Internalization of PA
The known cell-surface location and previously elucidated biological roles of LRP6 suggested that LRP6 deficiency might alter toxin lethality by impairing PA functions. To test this hypothesis, we examined the effects of lrp6-specific siRNAs on the ability of native anthrax toxin (i.e., PA + LF) to kill macrophages, which are a natural target for LF. Three siRNAs corresponding to sequences of the murine lrp6 gene were inserted in the pLENTI-SUPER vector and expressed stably in the murine macrophage cell line RAW264.7. Controls were nontransfected RAW264.7 cells and cells expressing siRNA1 directed against a human lrp6 sequence absent in the mouse gene. As shown in Figure 2A , MTT assay indicated increased survival in each of the three mouse-sequence-specific lrp6 siRNA pools of clones exposed to PA + LF. Western blot analysis of lysates from M2182 cells made resistant to toxin by either siRNA or antisense RNA against lrp6 transcripts showed a decrease in 83 kDa PA monomer bound to the cell surface ( Figure 2B ) and reduction of an SDS-resistant oligomeric form of PA that characteristically survives proteolytic treatment when cell cultures exposed to toxin complexes at 4ºC are shifted to 37ºC and the toxin complexes are internalized (Liu et al., 2003a) ( Figure 2C ). Additionally, deconvolution fluorescence microscopy using Alexa 488-labeled PA indicated that the abundance of PA both at the cell surface ( Figure 2D ) and in the cytoplasm ( Figure 2E ) was reduced in all LRP6-deficient clones examined, consistent with our biochemical evidence of decreased PA binding and internalization. Internalized PA colocalized with the early endosomal marker EEA1 (data not shown), in agreement with evidence that surface bound PA complexes are translocated into early endosomes after internalization (Leppla, 1995) .
The Intracellular Domain of LRP6 Is Essential for PA-Mediated Internalization and Toxin Lethality
The data presented above suggest that deficiency of LRP6 decreases both binding and internalization of PA. An LRP6 mutant protein (i.e., LRP6DC) that lacks most of the cytoplasmic domain ( Figure 2F ) and has been reported to have dominant-negative effects on Wnt signaling mediated by the coexisting wild-type LRP6 protein (Tamai et al., 2000) and an additional truncated LRP6 mutant protein that we expressed from pcDNA3.1 were tested for their ability to block PA-mediated cytotoxicity of FP59 in M2182 cells. Cell populations expressing each LRP6DC mutant protein were treated with PA (50 ng/ml) + FP59 (50 ng/ml) for 2 days, followed by extended growth on toxin-free medium. Whereas no survivors were observed among naïve M2182 cells or cells transfected with pcDNA3.1, colonies were seen within several days in cells (D) For PA binding assay, cells were incubated with Fluor 488-labeled PA for 1 hr at 4ºC before being examined by deconvolution microscopy following the protocol described in Experimental Procedures. Scale bar = 2.8 m.
(E) For PA internalization assays, cells were incubated with Fluor 488-labeled PA (1 mg/ml) for 45 min at 37ºC followed by deconvolution microscopy. Scale bar = 2.8 m.
(F) Schematic structure of dominant-negative mutant LRP6DC and wild-type LRP6 proteins. LRP6DC was generated by deleting amino acid residues from 1440 onward (Tamai et al., 2000) , as described in Experimental Procedures. (G) Effect of LRP6DC production on cellular response to Wnt activation. Luciferase reporter gene assay was carried out as in Figure 1E . The data shown are the averaged results of three independent experiments. The values shown represent the mean and standard deviation (bars). (H) Cytotoxicity assay of M2182 expressing LRP6DC, pLRP6DC-1, and pLRP6DC-8. Cell viability was assessed as described in Figure 1A . (I and J) Western blot analysis of bound (I) and internalized (J) PA in LRP6DC mutants. PA binding and internalization assays were carried out as described in Experimental Procedures using anti-PA monoclonal antibodies. a tubulin was used as an internal control.
expressing the pLRP6DC proteins (data not shown). Randomly picked clones from transfected cells containing the LRP6DC expression constructs were expanded to generate the M2182/pLRP6DC-1 and M2182/pLRP6DC-8 cell lines; assay of b catenin in these lines showed sharply reduced Wnt signaling ( Figure 2G ), confirming the dominant-negative effects of the LRP6DC proteins. Both clonal lines showed a dramatic and highly reproducible decrease in killing by PA + FP59 ( Figure 2H ). Moreover, whereas binding of the 83 kDa PA monomer to the cell surface was not detectably affected by overexpression of LRP6DC mutant proteins ( Figure 2I ), PA internalization, as monitored by the presence of PA oligomer after shift of the cell culture to 37ºC, was impaired ( Figure 2J ). These results argue strongly that LRP6 plays an essential role in accomplishing the internalization of PA and consequently in conferring cellular susceptibility to anthrax toxin. Moreover, the observed dominant-negative effects of the LRP6DC on PA-mediated cell death imply that the intracellular domain of LRP6, unlike the intracellular domain of the PA receptor, ATR/TEM8 (Liu and Leppla, 2003) , is essential for toxin lethality.
Disruption of Wnt Signaling or of Generalized Mechanisms of Endocytic Trafficking Does Not Impair Toxin Lethality
Is disruption of Wnt signaling a mechanism underlying the resistance to PA-mediated toxin lethality we observed in cells defective in LRP6 function? To address this question, we examined the effects of Axin, which regulates Wnt signaling downstream of entry of the Wnt/receptor complex into cells (Zeng et al., 1997; Itoh et al., 1998; Willert et al., 1999) , on the resistance of M2182 cells to PA + FP59. Whereas adventitious expression of Axin prevented induction of b catenin following addition of Wnt protein to cell cultures ( Figure 3A ), susceptibility to PA/FP59 toxin was unaltered by Axin expression ( Figure 3B ), indicating that interference with Wnt signaling per se does not result in toxin resistance.
Whether mitigation of anthrax toxin lethality by LRP6 deficiency is associated with more generalized effects on endocytic trafficking was addressed firstly by determining if LRP6-deficient cells show normal internalization and endocytic trafficking of a prototypical cell-surface receptor, the epidermal growth factor receptor (EGFR), and secondly Figure 3D , were subjected to the PA/FP59 toxin assay. The values shown represent the mean and standard deviation (bars).
by investigating whether cells having broad defects in endocytic trafficking exhibit resistance to toxin lethality. We observed that epidermal growth factor-induced internalization and degradation of EGFR was similar in parental M2182 cells, in clone ATR43, and in cells made toxin resistant by siRNA directed against LRP6 ( Figure 3C ). Conversely, cells that overexpress the mutant TSG101 or VPS4 proteins and consequently are broadly defective in endocytic trafficking (Bishop and Woodman, 2001; Strack et al., 2003; Lu et al., 2003) showed the expected abnormality of EGFR internalization/degradation ( Figure 3D) but unchanged lethality to PA + FP59 ( Figure 3E ). Thus, LRP6 deficiency does not result in a generalized defect in endocytic trafficking, and defective endocytic trafficking per se is not sufficient to mitigate toxin effects.
LRP6 Protein Interaction with PA Receptors TEM8 and CMG2 Is Required for Toxin Internalization Multiple coimmunoprecipitation (co-IP) experiments showed interaction between LRP6 and both of the previously identified cellular receptors for PA (i.e., TEM8 and CMG2) but no direct association of LRP6 with PA (E) 293T cells were transfected with LRP6N-Myc, Myc-LRP6DN, TEM8-HA, or a combination of two of them. Cell lysates combined with medium were treated with anti-HA-conjugated agarose beads before being subjected to immunoblot analysis probed with anti-c-Myc-HRP. (F) 293T cells were transfected with LRP6N-Myc, TEM8-HA, or both. Cell lysates combined with medium were treated with anti-HA-conjugated agarose beads in the presence or absence of PA (0.5 mg/ml) before being subjected to immunoblot analysis probed with anti-c-Myc-HRP. Chemiluminescence of Western blot bands was quantitated by using the VersaDoc Imaging System (Model 1000, Bio-Rad) and its software (Quantity One, Version 4.5.1).
Figure 5. LRP6 Effects on Internalization and Localization of PA and Its Receptors
(A and B) Deconvolution microscopy images (three independent image fields for each) showing the colocalization of Flag-LRP6 (red) and PA oligomers (green). M2182 cells were first transfected with Flag-LRP6 two days prior to fluorescence microscopy. Cells were incubated without PA (A) or with Fluor-488-conjugated PA (1 mg/ml) at 37ºC for 45 min (B). Flag-LRP6 protein labeled by Fluor-594 (red) is shown in the left panels (A and B). The PA oligomer signal (green) is shown in the middle panels. The right panels show the merged images, including DAPI nuclear staining (blue). Scale bar (A and B) = 2.8 m.
(C) Deconvolution microscopy images showing colocalization of Fluor-594-labeled TEM8-HA (red) with Fluor-488-conjugated PA (1 mg/ml) (green) after cells were incubated with PA (1 mg/ml) for 45 min at 37ºC (scale bar = 2.8 m). The top and bottom panels show two independent fields. The right panels show the merged images, including DAPI nuclear staining (blue). (D) Deconvolution microscopy images showing the colocalization of Flag-LRP6 (red) and CMG2-EGFP (enhanced green fluorescent protein) after cells were incubated with PA (1 mg/ml) for 45 min at 37ºC. Scale bar = 2.8 m.
(E and F) M2182 cells transfected with TEM8-HA or CMG2-EGFP were first incubated with or without PA (1 mg/ml) at 37ºC for 45 min before deconvolution microscopy. (E) Microscopy images showing aggregates (white arrows) of internalized TEM8-HA (red) in M2182 (top panels) or M2182/siRNA1 cells (bottom panels) in the absence (left panels) or presence (right panels) of PA. Scale bar = 5.6 m.
( Figure 4A ). In these experiments, the C-terminal Myctagged extracellular domain of LRP6 (LRP6N-Myc) was harvested from 293T cell growth medium and incubated with PA or with lysates containing HA-tagged TEM8 (TEM8-HA) or enhanced green fluorescent protein-tagged (EGFP-tagged) CMG2 (CMG2-EGFP); 293T lysates expressing N-terminal Flag-tagged full-length LRP6 (Flag-LRP6) were also examined by co-IP assay. LRP6 was detected in precipitates of TEM8-HA ( Figure 4B, top) , and TEM8 was observed in precipitates of Flag-LRP6 (Figure 4B, bottom) . Similar co-IP experiments carried out using TEM8-HA and LRP6N-Myc, which contains only the extracellular domain of LRP6 (i.e., LRP6N), indicated that this domain is sufficient for interaction with TEM8 (Figure 4C) . In additional experiments, we observed LRP6N in precipitates of CMG2-EGFP ( Figure 4D , top) and found CMG2 in precipitates containing LRP6N-Myc ( Figure 4D , bottom). However, we observed no interaction between either TEM8 or CMG2 and an LRP6-truncated protein lacking the extracellular domain ( Figure 4E ). As the precipitated bands from co-IP experiments that detected the interaction of LRP6 and PA receptors were faint in comparison with bands in the positive control lanes ( Figures  4B-4D) , we suspect that efficient interaction between LRP6 and PA receptors may involve accessory protein(s) that were not overexpressed in these experiments and which thus may be present in limiting amounts. Interestingly, while interaction binding of the LRP6 extracellular domain to TEM8 did not require PA, PA expression enhanced this interaction ( Figure 4F) ; we have not observed enhancement of the LRP6-CMG2 interaction by PA (data not shown).
As LRP6 initiates Wnt signaling when it enters cells together with other members of a Wnt-based complex (Mao et al., 2001) , we hypothesized that LRP6 may function similarly to promote internalization of PA and its receptors; deconvolution fluorescence microscopy experiments provided evidence of just such a role. As has been observed previously (Cong et al., 2004) , in the absence of PA, deconvolution microscopy showed that Alexa Fluor-594-stained (red) Flag-labeled LRP6 was present mainly in the cytoplasm as well as on the cell surface ( Figure 5A ). Addition of PA altered the location of internalized red fluorescent LRP6, resulting in its polar aggregation within the cytoplasm ( Figure 5B ). Furthermore, green fluorescence-labeled PA colocalized with cytoplasmic LRP6 ( Figure 5B ) and also with internalized TEM8 ( Figure 5C ). We were not able routinely to overexpress LRP6 concurrently with either TEM8 or CMG2 in the same cells (M2182); however, in rare instances when concurrent overexpression of both Flag-LRP6 and CMG2-EGFP was achieved, colocalization of LRP6 and CMG2 was observed in cells treated with PA (e.g., Figure 5D ). Expression of siRNA directed against LRP6 or dominantnegative LRP6DC prevented the occurrence of cytoplasmic aggregates of Alexa Fluor-594-stained TEM8-HA ( Figure 5E ) and EGFP-labeled CMG2 (Figure 5F ), which normally were observed after incubation of cells with PA for 45 min at 37ºC ( Figure 5E , top panels)-providing further evidence that the PA-mediated internalization of TEM8 and CMG2 is dependent on LRP6. Collectively, our immunoprecipitation and fluorescence microscopy results argue strongly that LRP6 forms a complex with PA receptors that accomplishes the translocation of PA and the bound toxin moieties into the cytoplasm.
LRP6 Antibodies Protect Cells from Anthrax Cytotoxicity
We generated rabbit polyclonal antibodies against two synthetic peptides that correspond to different segments of the extracellular domain of LRP6 and tested these antibodies (N204, directed against amino acids 204-223, and N251, directed against amino acids 515-534) ( Figure 6A ) for their ability to protect RAW264.7 macrophages from the lethal effects of anthrax toxin (PA + LF). Dosagedependent increased survival was observed for cells treated with N251, whereas antibody N204 provided no detectable protection from toxin killing ( Figure 6B ). Significantly, protection by antibody to N251 was partially reversed by the addition of peptide N251 but not by N204 ( Figure 6C ). H300, a commercially available rabbit polyclonal antibody generated against a LRP6 human protein fragment (amino acids 1314-1613) that includes a sequence of the cytoplasmic domain as well as segments of the extracellular and transmembrane domains (Figure 6A) , also provided dosage-dependent protection against killing by PA + LF ( Figure 6D ).
DISCUSSION
Role of LRP6 in Anthrax Toxicity
Using antisense RNA generated intracellularly against a library of ESTs to inactivate chromosomal genes globally in populations of human cells plus an experimental strategy that selected cell clones resistant to the actions of cytotoxins, we identified genes whose functional inactivation is causally related to toxin resistance. This approach uncovered lrp6, a member of a gene family encoding lowdensity lipoprotein (LDL) receptor-related proteins (LRPs) that reside on the cell surface and participate in the delivery of a variety of ligands into the cytoplasm (Orth et al., 1992; Kounnas et al., 1995; Stefansson et al., 1995; Howard et al., 1996; Li et al., 2001 ). The results reported here indicate that the LRP6 protein, which previously has been known principally as a mediator of the Wnt signaling pathway, has a hitherto unsuspected role in the delivery of anthrax toxins into cells. The role of LRP6 in PA-mediated toxigenicity was confirmed by multiple lines of evidence: (1) regulation of the toxin-resistance phenotype in clone ATR43 by tetracycline ( Figure 1B) ; (2) reproduction of the toxin-resistance phenotype by antisense expression of the lrp6 EST in naïve cells ( Figure 1F) ; (3) reproduction of the toxinresistance phenotype by siRNA corresponding to sequences in the lrp6 open reading frame (ORF) and partial reversal of this effect by overexpression of LRP6 protein containing silent mutations that make it nonsusceptible to inhibition by the siRNA ( Figures 1J and 1K) ; (4) creation of toxin resistance by expression of a dominant-negative truncated LRP6 mutant protein lacking the cytoplasmic domain of the protein ( Figure 2H) ; (5) protection of cells from anthrax toxicity by antibodies directed against epitopes in the LRP6 extracellular domain ( Figure 6) ; (6) biochemical evidence and deconvolution immunofluorescence microscopy results showing reduced internalization of PA in ATR43 cells and in cells expressing siRNAs directed against lrp6 mRNA ( Figure 2) ; and (7) our demonstration using both fluorescence microscopy and immunoprecipitation approaches that the LRP6 protein interacts with the PA receptors, TEM8 and CMG2, and controls PA-triggered internalization of the receptors (Figures 4 and 5) .
Biological Functions of LRP6 and Related Proteins LDL receptors and LDL receptor-related proteins (LRPs) are prototypes of macromolecules that interact with and deliver ligands into cells via endocytosis (Schneider and Nimpf, 2003) . LRP6 differs from other members of its family in that it contains a unique pattern of repeats of the epidermal growth factor receptor (EGFR) and LDL receptor (LDLR) sequences in the extracellular domain (Brown et al., 1998) . A notable characteristic of LRP proteins is their multifunctional nature. For example, LRP1 functions as a receptor for apoE-rich remnant lipoproteins, for lipoprotein lipase, for a 2-macroglobulin/protease complexes, for plasminogen activator/inhibitor complexes, for the active protease tissue-type plasminogen activator, and for the surface binding domain of exotoxin A from Pseudomonas aeruginosa (Willnow and Herz, 1994) . Our finding that LRP6 acts as a coreceptor to promote internalization of the PA component of anthrax toxin in addition to its previously known role in Wnt signaling indicates that LRP family proteins act more broadly in mediating the pathogenic effects of microbial toxins. Possibly related to our findings are results of DNA membrane array-based experiments showing that exposure of macrophages to the anthrax lethal toxin perturbs transcription of a variety of genes regulated by GSK-3b-including some implicated in Wnt signaling (Tucker et al., 2003) .
Interestingly, the possibility that LRP1 and LRP6 can interact functionally is suggested by recent evidence (Zilberberg et al., 2004 ) that LRP1 can sequester human Fz1 to disrupt the receptor/coreceptor complex formation and repress canonical Wnt signaling, raising the possibility that LRP6 may also modulate exotoxin A internalization. LRP5, another member of the LRP family that has 71% amino acid sequence identity to human LRP6, has also been implicated in Wnt signaling (Tamai et al., 2000) ; however, LRP5 has distinct effects on bone accrual and eye development (Gong et al., 2001) , and its presence does not mitigate either the embryonic lethality of LRP6 null mutations (Pinson et al., 2000) or the effects of LRP6 deficiency on anthrax toxicity (the studies reported here).
The EST library fragment (i.e., image clone 285207) identified in ATR43 cells corresponds to a sequence annotated as being present in an intron of human lrp6 RNA. While the occurrence of an apparently intronic fragment in the widely used EST library may indicate contamination of the library by genomic DNA, interference with LRP6 function by antisense RNA directed against this image clone sequence suggests that it may in fact be exonic. Analysis using the Human BLAT Search program (http:// genome.ucsc.edu/cgi-bin/hgBlat) indicated that the EST that constitutes image clone 285207 corresponds also to a sequence of the noncoding strand of an intron of a Bcl-2-like gene (Bcl2L14).
Mechanistic Model for LRP6 Effects on Toxin Lethality
The data reported here suggest the following model for the role of LRP6 in anthrax toxicity (Figure 7) . Independently of the presence of PA, LRP6 protein at the cell surface is capable of interacting with two proteins previously identified as PA receptors: TEM8/ATR and CMG2 (Bradley et al., 2001; Scobie et al., 2003) . Our data suggest that LRP6 deficiency reduces PA binding to the cell surface ( Figure 2B ) and also indicate that PA addition enhances binding of LRP6 to the PA receptors. Upon addition of PA, a complex containing PA, LRP6, and the PA receptors TEM8 or LRP6 is proposed to act as a coreceptor for PA through its binding to TEM8/ATR and/or CMG2. PA addition triggers the internalization of this complex, which delivers PA and associated toxin molecules into cells.
CMG2 is formed and then internalized together with the associated toxin moieties, LF or EF. This model is consistent with earlier evidence that neither TEM8 nor CMG2 is sufficient to carry toxin into the cells. The essential role of LRP6 in enabling entry of receptor bound anthrax toxin into cells parallels its previously demonstrated role in Wnt pathway signaling (Mao et al., 2002) . In that case, the transmembrane protein Kremen2 forms a ternary complex with the Wnt antagonist DKK-1 and LRP6, triggering LRP6-mediated endocytosis of all three components and consequent modulation of Wnt/b-catenin signaling. Whether other cellular proteins are included in the PA/receptor/coreceptor complex and the stoichiometry of complex formation currently is not known.
Our observation of perinuclear localization of adventitiously expressed Flag-tagged LRP6 in M2182 cells (Figure 5) is consistent with recent independent evidence that LRP6 can exist intracellularly in the perinuclear region as well as at the plasma membrane of 293T cells (Cong et al., 2004) . Addition of PA increased the abundance of cytoplasmic LRP6 and altered its location, producing polar aggregates that colocalize with PA ( Figure 5B ). The ability of antibodies against LRP6 extracellular domains to protect cells from anthrax toxin killing ( Figure 6 ) argues that at least some of the LRP6 protein that colocalizes with PA in the cytoplasm is derived from the cell surface. The ring-shaped heptamer structure generated by spontaneous oligomerization of receptor bound PA (i.e., the prepore) (Milne et al., 1994 ) is responsible for carrying EF or LF into early endosomes, where PA heptamers form an aqueous transmembrane channel that mediates translocation of EF and LF to the cytosol (Blaustein et al., 1989) . Whether LRP6 and the PA receptors are involved mechanistically in the formation of the prepore structure has not been determined.
Our discovery of the role of LRP6 in anthrax toxicity and the demonstration that antibodies directed against the extracellular domain of LRP6 can protect cells grown in culture against killing by anthrax toxin suggest that the immunological targeting of LRP6 may prove useful in protecting against the effects of accumulated toxin during the late stages of anthrax disease when antibacterial methods normally are no longer of therapeutic value.
EXPERIMENTAL PROCEDURES
Cell culture, construction and screening of cDNA libraries, and construction and cloning of expression vectors have carried out using variations of methods reported previously (Lu et al., 2004) ; these are described in detail in Supplemental Data.
Toxin Treatment and Cell Viability Assay Proteins produced as described previously (Leppla, 1988) include wildtype PA, FP59, and LF. Cytotoxicity assays for M2182 were performed by treating cells at a concentration of 5 Â 10 4 cells/well (in 6-well plates)
with PA (30 ng/ml) plus FP59 (50 ng/ml) for 2 days. Cells were cultured in toxin-free medium for 3 days after toxin challenge before being stained with crystal violet for microscope imaging and photography. For MTT assay, cells were seeded in 96-well plates (100 ml/well) 1 day prior to toxin treatment; the cell concentration used was 5 Â 10 4 /ml for M2182 cell line and 3 Â 10 4 /ml for RAW264.7 cell line. Various concentrations of PA combined with a fixed concentration of FP59 (50 ng/ml) (for M2182 line) or LF (500 ng/ml) (for RAW264.7 line) were added to wells, and cells were incubated for 48 hr at 37ºC. Cell viability was measured by adding 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) (Sigma) to a final concentration of 1 mg/ml for 1 hr at 37ºC. The supernatant was carefully removed before the addition of 50 ml of solubilization solution (10% SDS in 0.01 N HCl) and subsequently of 200 ml of PBS to each well. Spectrophotometer readings at 570 nm were determined using a GENios Multi-Detection Reader (TECAN, Phenix Research Products). Cell viability was normalized to wells lacking PA. Each data point shown in figures for MTT assays represents the averaging of results from eight wells.
Preparation of LRP6-Specific Short Interfering RNAs
Three human-specific lrp6 sequences (tgctacgattgtagttgga, cgaatc gaattgaggtgtc, tgtctcgaggtaaatcaat) and three murine-specific lrp6 sequences (gagaatgcaacgattgtag, gtgctttgtttaattgatc, atacacatctggtt gagat) were selected. The siRNA duplexes were cloned into the pLENTI-SUPER lentiviral vector (derived from pSUPER) (Brummelkamp et al., 2002) . siRNA constructs were then introduced into cells by infection. Stable clones of cells carrying siRNAs were selected using blasticidin (10 mg/ml) (Sigma). The scrambled siRNA control was a product from Ambion (Austin, TX).
Assay for Luciferase Reporter Gene Activity and EGF Receptor Degradation
These assays were performed as reported in (Veeman et al., 2003; Lu et al., 2003) and described in detail in Supplemental Data.
Biochemical Assay of PA Binding and Internalization Methods were as described by Liu et al. (2003a Liu et al. ( , 2003b , except that the final concentration of PA and its incubation time were 0.05 mg/ml for 2 hr and 1 mg/ml for 45 min, respectively.
Western Blotting and Coimmunoprecipitation
Western blotting was performed essentially as described by Harlow and Lane (1999) using precast 10% or 3%-8% gels (Criterion XT Precast Gel, Bio-Rad) for electrophoresis and standard conditions. The soluble cell proteins were quantitated using the BCA protein assay kit (Pierce Biotechnology, Inc.). For coimmunoprecipitation assays, 293T cells, 48 hr after transfection, were lysed in NP40 buffer containing a protease inhibitor cocktail (Complete Mini, Roche Diagnostics, Inc.). The lysates were centrifuged at 16,000 Â g, and the soluble fraction was immunoprecipitated with the desired antibody-conjugated agarose beads (Santa Cruz Biotechnology, Inc.). The cell medium was included in LRP6N-Myc immunoprecipitation reactions because LRP6N-Myc is secreted into the supernatant (Tamai et al., 2000) after being expressed.
Antibody Reagents
Polyclonal antibody against PA was generated as described in Liu et al. (2003b) , and monoclonal antibody against PA was ordered from Novus Biologicals (NB 600-407). Rabbit polyclonal antibody against human LRP6 (H300) was purchased from Santa Cruz Biotechnology, Inc., and monoclonal anti-LRP5/6 antibody that was generated against a synthetic peptide derived from an amino acid sequence (DTGT DRIEVTR) of the second YWTD repeat of LRP6 was obtained from A&G Pharmaceuticals (Baltimore, MD) and BioVision (Mountain View, CA). Rabbit polyclonal antibodies N204 & N251 were generated for us by Proteintech Group, Inc. (Chicago, IL) using synthetic peptides derived from amino acid sequences (NFIHKSNLDGTNRQAVVKGS for N204 and EVMNTDGTGRRVLVEDKIPH for N251). Agarose-conjugated monoclonal antibodies of c-Myc (9E10), HA (F-7), and GFP (B-2) and horse radish peroxidase (HRP)-conjugated monoclonal antibodies against c-Myc (9E10), HA (F-7), and GFP (B-2) were all obtained from Santa Cruz Biotechnology, Inc. Anti-Flag (M2) monoclonal antibodies against the HRP-conjugate and affinity gels used for co-IP experiments were obtained from Sigma, Inc.
Immunofluorescence Microscopy PA protein was labeled with Alexa Fluor 488 using the protein labeling kit (A-10235, Molecular Probes, Inc.). The potency of PA after labeling was fully retained as indicated by the MTT assay (data not shown). The concentrations of PA-Alexa 488 used in analysis of PA binding and processing were 0.6 mg/ml and 1 mg/ml, respectively. Immunostaining was performed according to a standard protocol (Harlow and Lane, 1999) . The primary antibody anti-Flag (M2) (murine monoclonal, Sigma, Inc.) was used at a dilution of 1:200. Alexa-Fluor 594 goat anti-mouse IgG (Molecular Probes) was used as the secondary antibody at a dilution of 1:400. The preconjugated antibody anti-HA-Alexa Fluor-594 (murine monoclonal IgG 1 , 16B12, Molecular Probes) was also used. The cover slips were mounted onto slides with a ProLong Gold antifade reagent containing DAPI solution (Molecular Probes), and cells were examined under a deconvolution microscope (Applied Precision, Issaquah, WA).
Antibody Protection Assay 3 Â 10 4 /ml of RAW264.7 cells were first seeded in 96-well plates (100 ml/well) the day prior to the assay. The cells were then incubated at 37ºC for 48 hr with 3 ng/ml of PA, 500 ng/ml of LF, and serial dilutions of antibodies. To test the specificity, the antibody was preabsorbed with the N204 or the N251 peptide prior to assay. The antibody was incubated with peptide in the ratio of 2 mg peptide /1 ml final bleed on a rotator at 4ºC overnight, followed by a centrifugation at 14,000 RPM for 10 min to remove the precipitate. Toxin sensitivity was determined by the cell viability as described above.
Supplemental Data
Supplemental Data include Experimental Procedures and References and can be found with this article online at http://www.cell.com/cgi/ content/full/124/6/1141/DC1/.
